These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13984681)

  • 1. Urinary recovery of salicylamide as its glucuronide in liver disease.
    TAKETA K
    Acta Med Okayama (1952); 1962 Jun; 16():129-36. PubMed ID: 13984681
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on bilirubin glucuronide. 2. A study on conjugated bilirubin fraction in bile and bilirubin glucuronide].
    Takagi M
    Igaku Kenkyu; 1969 Jun; 39(3):265-74. PubMed ID: 5389948
    [No Abstract]   [Full Text] [Related]  

  • 3. Salycylamide glucuronide formation in liver disease and its change by drugs.
    Adachi Y; Wakisaka G; Yamamoto T
    Gastroenterol Jpn; 1975; 10(2):120-31. PubMed ID: 10219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic glucuronyl-transferase activity in congenital and acquired liver disease.
    Frzza M; De Sandre G; Perona G
    Acta Hepatosplenol; 1970; 17(3):165-74. PubMed ID: 5421887
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary glucuronic acid excretion in liver disease and the effect of a salicylamide load.
    BARNIVILLE HT; MISK R
    Br Med J; 1959 Feb; 1(5118):337-40. PubMed ID: 13618635
    [No Abstract]   [Full Text] [Related]  

  • 6. Salicylamide-Glucuronide formation in children with favism and in their parents.
    Cutillo S; Costa S; Vintuleddu MC; Meloni T
    Acta Haematol; 1976; 55(5-2):296-9. PubMed ID: 821294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiochemical plasma salicylamide assay using ring-labeled tritiated salicylamide.
    Stella VJ; Varia SA; Riedy M
    J Pharm Sci; 1979 May; 68(5):648-50. PubMed ID: 430509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.
    READ AE; SHERLOCK S; HARRISON CV
    Gut; 1963 Dec; 4(4):378-93. PubMed ID: 14084750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.
    Levy G; Procknal JA
    J Pharm Sci; 1968 Aug; 57(8):1330-5. PubMed ID: 5677334
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycurone conjugation in the premature infant. In vivo study by means of salicylamide test].
    Ciampolini M; Carattoli MT; Pietraperzia M
    Riv Clin Pediatr; 1969; 82():185-91. PubMed ID: 5408545
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic studies of glucuronide formation in impaired liver. IV. Liver glucuronyl transferase activity and uridine diphosphate glucuronic acid content in viral hepatitis patients.
    TAKETA K
    Acta Med Okayama (1952); 1962 Jun; 16():115-28. PubMed ID: 13984680
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of salicylamide administration on D-glucuronic acid metabolism in the rat.
    Hänninen O
    Ann Acad Sci Fenn A; 1966; 123():1-66. PubMed ID: 5908696
    [No Abstract]   [Full Text] [Related]  

  • 13. [The glucuronide pattern after peroral dosage with acetanilide in chronic hepatitis and liver cirrhosis].
    Hammar CH; Prellwitz W
    Klin Wochenschr; 1966 Sep; 44(17):1010-4. PubMed ID: 5993592
    [No Abstract]   [Full Text] [Related]  

  • 14. The test of urinary elimination of carbonylated bodies as expressed in terms of pyruvic acid, in the course of epidemic hepatitis, chronic hepatitis and cirrhosis.
    IAGNOV S; ZAMFIRESCU-GHEORGHIU M
    Rum Med Rev; 1957; 1(4):19-22. PubMed ID: 13528891
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of salicylamide elimination in man.
    Levy G; Matsuzawa T
    J Pharmacol Exp Ther; 1967 May; 156(2):285-93. PubMed ID: 6026259
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of salicylamide glucuronidation by bacterial lipopolysaccharide.
    Kushiya M; Hasegawa R; Komuro T; Isaka H
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):416-20. PubMed ID: 3594667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biopharmaceutical studies of drugs. II. The competitive inhibition of pentazocine glucuronidation by salicylamide in vitro (author's transl)].
    Kigasawa K; Shimizu H; Saito M; Hayashi T
    Yakugaku Zasshi; 1980 Mar; 100(3):249-55. PubMed ID: 7381685
    [No Abstract]   [Full Text] [Related]  

  • 19. [The Jirgl test in the differential diagnosis of jaundices].
    VILLALOBOS JJ; DIAZ GARZA R; REYES VERA MENDEZ L
    Rev Invest Clin; 1963; 15():55-61. PubMed ID: 13997266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biopharmaceutical studies of drugs. I. Effect of salicylamide on serum concentration of pentazocine after oral administration (author's transl)].
    Kigasawa K; Shimizu H; Saito M; Hayashi T; Tanaka M
    Yakugaku Zasshi; 1980 Mar; 100(3):244-8. PubMed ID: 7381684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.